Kinase modulators
US-11858907-B2 · Jan 2, 2024 · US
This page is not indexed by search engines while we improve data quality.
Rhizen Pharmaceuticals Sa — Cross-Sectional Technologies
Rhizen Pharmaceuticals Sa holds 57 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Rhizen Pharmaceuticals Sa |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 57 |
| Recent patents in slice | 1 |
| First year | 2015 |
| Last year | 2024 |
Representative patents
Notable publications linking Rhizen Pharmaceuticals Sa to Cross-Sectional Technologies.
Novel selective pi3k delta inhibitors
US-2021403475-A1 · Dec 30, 2021 · US
Forms of a pi3k delta selective inhibitor for use in pharmaceutical formulations
US-2021269446-A1 · Sep 2, 2021 · US
Intermediates useful in the synthesis of compounds as modulators of protein kinases
US-11020399-B2 · Jun 1, 2021 · US
Selective PI3K delta inhibitors
US-10981919-B2 · Apr 20, 2021 · US
Recent filings
Latest patents from Rhizen Pharmaceuticals Sa in Cross-Sectional Technologies.
Kinase modulators
US-11858907-B2 · Jan 2, 2024 · US
Novel selective pi3k delta inhibitors
US-2021403475-A1 · Dec 30, 2021 · US
Forms of a pi3k delta selective inhibitor for use in pharmaceutical formulations
US-2021269446-A1 · Sep 2, 2021 · US
Intermediates useful in the synthesis of compounds as modulators of protein kinases
US-11020399-B2 · Jun 1, 2021 · US
Selective PI3K delta inhibitors
US-10981919-B2 · Apr 20, 2021 · US
Related pages
Navigate to parent entity pages.